Apolipoprotein E (APOE) polymorphisms related to AD risk influence Lp-PLA2 activity levels [7], yet the null activity polymorphism of the Lp-PLA2 gene was not associated with lower risk of AD in a large case-control study in Japan [8]. This evidence concerns the gene APOE and Alzheimer disease.